Latest Breaking News On - Caribou biosciences inc - Page 1 : comparemela.com

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Avidity Partners Management LP

Avidity Partners Management LP lifted its holdings in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 5.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,360,212 shares of the company’s stock after acquiring an additional 310,000 shares during the quarter. […]

Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Caribou Biosciences : Corporate Presentation May 2024

May 2024 Corporate presentation Transformative genome-edited therapies for patients .

Caribou Biosciences Presents Encouraging Clinical Data from

CB-010 allogeneic CAR-T cell therapy with partial HLA matching has potential to rival efficacy and safety profile of approved autologous CAR-T cell.

Caribou Biosciences : KOL discussion of CB-010 ANTLER Phase 1 final trial data at ASCO

June 2, 2024 CB-010 ANTLER Phase 1 trial update and KOL discussion Transformative genome-edited.